CANbridge Pharmaceuticals
James Xue is currently serving as Deputy Director General at Shanghai Foundation for Rare Disease and China Alliance for Rare Disease (CHARD). Previously, James held various leadership positions at CANbridge Pharmaceuticals Inc., Tullis Health Investors, CANbridge Consulting LLC, and Genzyme Corporation. With a strong background in pharmaceuticals and healthcare, James has a Ph.D. in Bioorganic Chemistry from Brown University and an MBA from the University of Virginia Darden School of Business.
This person is not in any offices
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .